P109: One-Day Brentuximab-Bendamustine (120mg/m2) every 21 days is a feasible and safe treatment for relapsed/refractory Hodgkin lymphoma

por Moatti, Hannah, Laroque, Marie-Céleste, Renaud, Loïc., Ravdan, Odonchimeg, Schmidt-Hieber, Charlotte, Madelaine, Isabelle, Di Blasi, Roberta, Thieblemont, Catherine, Brice, Pauline
Publicado 2022